Interactions between inflammatory mediators in expression of antitumor cytostatic activity of macrophages
- 30 September 1990
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 25 (4), 295-301
- https://doi.org/10.1016/0165-2478(90)90199-z
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Specific lipoxygenase inhibition reverses macrophage cytotasis towards P815 tumor cells in vitro induced by the calcium lonophore A23187Prostaglandins, Leukotrienes & Essential Fatty Acids, 1988
- Cytostatic product(s) released by activated macrophages, unrelated to interleukin 1, tumor necrosis factor α, and interferon-αβCellular Immunology, 1988
- The pharmacologic regulation of interleukin-1 production: The role of prostaglandinsCellular Immunology, 1988
- Multiple biological activities of human recombinant interleukin 1.Journal of Clinical Investigation, 1986
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Cyclooxygenase inhibitors promote the leukotriene C4 induced release of β-glucuronidase from rat peritoneal macrophages: Prostaglandin E2 suppressesInternational Journal of Immunopharmacology, 1986
- Interleukin-1Clinical Infectious Diseases, 1984
- Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Minireview with emphasis on macrophage-mediated effectsInternational Journal of Immunopharmacology, 1982
- Prostaglandin regulation of macrophage function: Effect of endogenous and exogenous prostaglandinsCellular Immunology, 1982
- Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophagesCellular Immunology, 1975